Back
Rhythm Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
71
RYTM
Rhythm Pharmaceuticals
Last Price:
$90.73
Seasonality Move:
17.77%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
Rhythm Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 83.28 | Buy |
| 20-day SMA: | 71.26 | Buy |
| 50-day SMA: | 65.95 | Buy |
| 200-day SMA: | 58.4 | Buy |
| 8-day EMA: | 72.89 | Buy |
| 20-day EMA: | 43.7 | Buy |
| 50-day EMA: | 21.04 | Buy |
| 200-day EMA: | 5.8 | Buy |
Rhythm Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 24.2 | Buy |
| Relative Strength Index (14 RSI): | 79.96 | Buy |
| Chaikin Money Flow: | 412921 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (58.85 - 80.81) | Buy |
| Bollinger Bands (100): | (52.23 - 69.71) | Buy |
Rhythm Pharmaceuticals Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rhythm Pharmaceuticals Stock
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 91.44 while RYTM 8-day simple moving average is 83.28, which is a Buy signal.
-
The stock price of RYTM is 91.44 while Rhythm Pharmaceuticals 20-day SMA is 71.26, which makes it a Buy.
-
Rhythm Pharmaceuticals 50-day simple moving average is 65.95 while RYTM share price is 91.44, making it a Buy technically.
-
RYTM stock price is 91.44 and Rhythm Pharmaceuticals 200-day simple moving average is 58.40, creating a Buy signal.
RYTM Technical Analysis vs Fundamental Analysis
Buy
71
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy or a Sell?
-
Rhythm Pharmaceuticals stock is rated a BuyThe current Rhythm Pharmaceuticals [RYTM] share price is $91.44. The Score for RYTM is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
Rhythm Pharmaceuticals Stock Info
Market Cap:
6B
Price in USD:
91.44
Share Volume:
727.4K
Rhythm Pharmaceuticals 52-Week Range
52-Week High:
94.80
52-Week Low:
40.61
Buy
71
Rhythm Pharmaceuticals (RYTM)
is a Buy
Rhythm Pharmaceuticals Share Price Forecast
-
What is the Rhythm Pharmaceuticals stock price today?The Rhythm Pharmaceuticals stock price is 91.44 USD today.
-
Will RYTM stock go up or go down?Rhythm Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Rhythm Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rhythm Pharmaceuticals is not overvalued.
Is Rhythm Pharmaceuticals Stock a Buy?
-
Rhythm Pharmaceuticals share price is 91.44 while RYTM 8-day exponential moving average is 72.89, which is a Buy signal.
-
The stock price of RYTM is 91.44 while Rhythm Pharmaceuticals 20-day EMA is 43.70, which makes it a Buy.
-
Rhythm Pharmaceuticals 50-day exponential moving average is 21.04 while RYTM share price is 91.44, making it a Buy technically.
-
RYTM stock price is 91.44 and Rhythm Pharmaceuticals 200-day simple moving average is 5.80, creating a Buy signal.
Fundamental Analysis of Rhythm Pharmaceuticals
Is Rhythm Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.12 per share, an increase this year of $1.23 per share, and an increase next year of $1.08 per share.
Technical Analysis of Rhythm Pharmaceuticals
Should I short Rhythm Pharmaceuticals stock?
-
RYTM Moving Average Covergence Divergence (MACD) indicator is 24.2, suggesting Rhythm Pharmaceuticals is a Buy
-
Rhythm Pharmaceuticals Relative Strength Index (RSI) is 79.96, which suggest Rhythm Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Rhythm Pharmaceuticals is (58.85 - 80.81), which suggest Rhythm Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Rhythm Pharmaceuticals is (52.23 - 69.71), which suggest Rhythm Pharmaceuticals is a Buy
* Rhythm Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.